TickerFacts.

Stemtech Corp (STEK): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$2.54M
Year ended 2025-12-31
-$2.16M
Trailing 12 months to 2026-06-30
2020-12-31: -$1.00M2021-12-31: -$2.78M2022-12-31: -$4.58M2023-12-31: -$3.64M2024-12-31: -$2.04M2025-12-31: -$2.54M-$2.54M
2020-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$2.54Mn/m2026-05-29, From 2025-01-01
2024-12-31-$2.04Mn/m2026-05-29, From 2024-01-01
2023-12-31-$3.64Mn/m2025-06-30, From 2023-01-01
2022-12-31-$4.58Mn/m2024-07-10, From 2022-01-01
2021-12-31-$2.78Mn/m2023-04-17, From 2021-01-01
2020-12-31-$1.00Mn/a2022-04-01, From 2020-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Stemtech Corp (STEK)2025-12-31-$2.54Mn/m
DataMeds AI, Inc. (MEDS)2025-12-31-$90.54Mn/m
Cosmos Health Inc. (COSM)2025-12-31-$15.33Mn/m
Nu Skin Enterprises, Inc. (NUS)2025-12-31$118.02Mn/m
Herbalife Ltd. (HLF)2025-12-31$602.20M+18.7%
Cardinal Health Inc (CAH)2026-06-30$3.57B+16.4%
Cencora, Inc. (COR)2025-09-30$3.68B+12.6%
McKesson Corp (MCK)2026-03-31$6.94B+37.2%

Compare STEK, MEDS, COSM, NUS side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗